RT Journal Article
SR Electronic
T1 Clinical characteristics of critically ill patients with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.09.20246413
DO 10.1101/2020.12.09.20246413
A1 Bisso, Indalecio Carboni
A1 Huespe, Iván
A1 Lockhart, Carolina
A1 Massó, Agustín
A1 González Anaya, Julieta
A1 Hornos, Micaela
A1 Famiglietti, Romina
A1 Di Grazia, Marcelo
A1 Coria, Pablo
A1 Román, Eduardo San
A1 Heras, Marcos Las
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.09.20246413.abstract
AB Objective Describe the clinical and respiratory characteristics of critical patients with coronavirus disease 2019 (COVID-19).Design Observational and retrospective study over 6 months.Setting Intensive care unit (ICU) of a high complexity hospital in Buenos Aires, Argentina.Patients Patients older than 18 years with laboratory-confirmed COVID-19 by reverse transcriptase-polymerase chain reaction (RT-PCR) for SARS-CoV-2 were included in the study.Variables of interest Demographic characteristics such as sex and age, comorbidities, laboratory results, imaging results, ventilatory mechanics data, complications, and mortality were recorded.Results A total of 168 critically ill patients with COVID-19 were included. 66% were men with a median age of 65 years (58-75. 79.7% had at least one comorbidity. The most frequent comorbidity was arterial hypertension, affecting 52.4% of the patients. 67.9 % required invasive mechanical ventilation (MV), and no patient was treated with non-invasive ventilation. Most of the patients in MV (73.7%) required neuromuscular blockade due to severe hypoxemia. 36% of patients were ventilated in the prone position. The length of stay in the ICU was 13 days (6-24) and the mortality in the ICU was 25%.Conclusions In this study of critical patients infected by SARS-CoV-2 in a high-complexity hospital, the majority were comorbid elderly men, a large percentage required invasive mechanical ventilation, and ICU mortality was 25%.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Hospital Ethics Committee in March 2019.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available.